Circassia Group (CIR): Corp Completion of transaction with AstraZeneca | DX (DX): Corp Trading better than anticipated | Oncimmune Holdings (ONC): Corp Contract with Roche | Sopheon (SPE): Corp Accolade 13.1 | Synairgen (SNG): Corp COVID-19 trial completes enrolment of first stage
28 May 2020
Morning Note – 28 May 2020
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 28 May 2020
- Published:
28 May 2020 -
Author:
Andrew Darley | Guy Hewett | Mark Brewer | Cavendish Research -
Pages:
8
Circassia Group (CIR): Corp Completion of transaction with AstraZeneca | DX (DX): Corp Trading better than anticipated | Oncimmune Holdings (ONC): Corp Contract with Roche | Sopheon (SPE): Corp Accolade 13.1 | Synairgen (SNG): Corp COVID-19 trial completes enrolment of first stage